PLoS Clinical Trials: Call for Papers

Dear Dr.,

As a triallist, Iím hoping that you will be interested in a new open-access medical journal that the Public Library of Science is launching in May of this year: PLoS Clinical Trials. The journal is now accepting manuscripts, and Iíd like to invite you to submit a paper.

Hereís why you should consider submitting

First, all articles are freely available online to everyone, everywhere—and you retain copyright. This is the beauty of open-access: you get the widest possible audience for your work. The journal already has several thousand registrants for Content Alerts—even before we have published a manuscript—and these numbers are growing daily.

Second, you may be aware that many completed trials are thought to go unpublished, distorting the evidence base for decision-making in healthcare. PLoS Clinical Trials will address the systematic under-reporting of clinical trials by considering all randomized trials for publication—regardless of outcome or specialty scope—as long as they are appropriately conducted and reported. Planned follow-up studies are also welcome.

Third, all manuscripts will be rigorously peer-reviewed by statistical and clinical reviewers. Peer review will be carried out in close consultation with the journalís international advisory and editorial boards. And, with continuous online publication, your manuscript will be published as soon as it is ready, not when the next issue is available.

Please go to the website at www.plosclinicaltrials.org for more information and to see a list of the outstanding scientists and clinicians on our advisory and editorial boards. You can register for content alerts and submit your trial online via the site.

Feel free to contact me directly with your queries and feedback at eveitch@plos.org.

Sincerely,

Emma Veitch, PhD
Publications Manager, PLoS Clinical Trials
eveitch@plos.org